Home LiteratureArticle Details
PMID: 2234498 Published · ppublish English Journal Article Research Support, U.S. Gov't, P.H.S.

Potassium channel activators abolish excitotoxicity in cultured hippocampal pyramidal neurons.

Neuroscience letters ·Vol. 115 ·No. 2-3 ·1990-07-31 ·Pages 195-200

Abele AE, Miller RJ

Abstract

When hippocampal pyramidal neurons are grown in culture they develop excitatory synaptic contacts. If these cultures are perfused with Mg2(+)-free, glycine supplemented medium the neurons exhibit fluctuations in [Ca2+]i and associated cell death ('excitotoxicity'). These phenomena involve the activation of NMDA receptors. When cultures are treated with the K(+)-channel activators cromakalim and diazoxide both the [Ca2+]i fluctuations and the neuronal death are abolished. These effects are reversed by the sulfonylurea glyburide. It thus appears that K(+)-channel activators may be a novel therapeutic intervention in epilepsy and associated disorders.

MeSH Terms
Action Potentials/drug effects Animals Benzopyrans/pharmacology Cell Survival/drug effects Cells, Cultured Cromakalim Diazoxide/pharmacology Hippocampus/drug effects,physiology Potassium Channels/drug effects,physiology Pyrroles/pharmacology Rats
Chemicals
Benzopyrans Potassium Channels Pyrroles Cromakalim Diazoxide
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Abele A E
Department of Pharmacological Sciences, University of Chicago, IL 60637.
Miller R J
Article Info
Journal
Neuroscience letters
Abbr.
Neurosci Lett
ISSN
0304-3940
Published
1990-07-31
Pages
195-200
Language
English
Region
Ireland
NLM ID
7600130
Subset
IM
Grants
NIDA NIH HHS · DA-02121 · United States
NIDA NIH HHS · DA-02575 · United States
NIMH NIH HHS · MH-40165 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com